medline.ch Neurologie Multiple Sklerose

	Machine Learning Analysis Applied to Prediction of Early Progression Independent of Relapse Activity in Multiple Sclerosis Patients. Eur J Neurol Poretto V, Endrizzi W, Betti M, Bovo S, Bellinvia A, Ragni F, Lapucci C, Moroni M, Marangoni S, Portaccio E, Longo C, Gios L, Chierici M, Jurman G, Giometto B, Inglese M, Osmani V, Marenco M, Uccelli A, Amato MP. PMID: 41312659 [PubMed - indexed for MEDLINE]
	Fear of disease progression and relapse in multiple sclerosis: a systematic scoping review. Front Psychiatry Mallahzadeh A, Fereydoonnezhad T, Gauthier LV, Farjoud Kouhanjani M, Hosseinizadeh S, Khatibi A. PMID: 41311821 [PubMed]
	Comparative Efficacy of Ublitixumab Versus Natalizumab in the Treatment of Relapsing and Remitting Multiple Sclerosis. Cureus Chitturi SV, Amith Priyansu J, Sadhu A, Ramisetty H, Pallapothu MR, Kogantii D. PMID: 41311752 [PubMed]
	Effectiveness of Dry Cupping Therapy on Fatigue and Quality of Life of Women with Multiple Sclerosis: Randomized Clinical Trial. Iran J Nurs Midwifery Res Sohrabi F, Tirgari B, Forouzi MA, Roy SC, Tajadini H, Jahani Y, Seifaddini R. PMID: 41311603 [PubMed]
	Is therapy-free remission a realistic goal with cladribine tablets in multiple sclerosis? New insights into the mechanism of action and clinical implications of immune reconstitution with cladribine tablets in MS therapy. J Neurol Kleinschnitz C, Skripuletz T, Pfeuffer S, Pawlitzki M, Rieckmann P, Penner IK, Knaup J, Wagner T, Hübschen M, Hellwig K, Pul R. PMID: 41310199 [PubMed - indexed for MEDLINE]
	Towards primary prevention of multiple sclerosis. Nat Rev Neurol Dobson R, Kreft KL, Jacobs BM, Brown JWL, Thomson A, Nicholas R, Walton C, Narendran P, UK MS Prevention Taskforce. PMID: 41310024 [PubMed - as supplied by publisher]
	"Understanding Glial Cells: Implications for Multiple Sclerosis Pathogenesis and Therapeutics". Ageing Res Rev Lalmani YS, Deshmukh R. PMID: 41308840 [PubMed - as supplied by publisher]
	Wearable-based physiological monitoring and brain magnetic resonance imaging metrics in multiple sclerosis: A feasibility study. J Neuroimmunol Miyazaki Y, Yokote H, Fujimori J, Sakurai K, Hagiwara A, Fujino S, Fukami T, Takahashi E, Miyagishi M, Uwatoko M, Sugimura Y, Amino I, Akimoto S, Izumi K, Minato K, Minami N, Niino M. PMID: 41308241 [PubMed - as supplied by publisher]
	Mortality trends in multiple sclerosis and cardiovascular disease in adults in the United States: A 25-year mortality perspective. Mult Scler Relat Disord Hemida MF, Ibrahim AA, Shahriar Z, Khalid M, Zeeshan N, Qaisi W, Hussein M, Sarfraz MR, Rabie OM, Saghir M, Saghir E, Jalal AA, Alagamy M, Tabasum P, Ahmed R. PMID: 41308235 [PubMed - as supplied by publisher]
	Functional connectivity changes are associated with disability progression in multiple sclerosis: a longitudinal fMRI study. J Neurol Piervincenzi C, Ojha A, Tommasin S, Satriano F, Petsas N, Gallo A, d'Ambrosio A, De Stefano N, Cortese R, Valsasina P, Tedone N, Pozzilli C, Rocca MA, Filippi M, Pantano P, INNI Network. PMID: 41307737 [PubMed - indexed for MEDLINE]
	Gait Kinematics Assessed by Vicon(Â®) and Quality of Life Correlations in Multiple Sclerosis Patients: A Cross-Sectional Study. Sensors (Basel) Micolas O, Gil-Gregorio M, Uría-Oruezábal AM, López-González R, González-de-la-Flor Á, Giménez MJ, García-Arrabé M, Estrada-Barranco C. PMID: 41305115 [PubMed - indexed for MEDLINE]
	The Age-Related Efficacy of Dimethyl Fumarate in Naive Versus Switcher Multiple Sclerosis Patients: A Multicenter Population-Based Study. Pharmaceuticals (Basel) De Masi R, Orlando S, Greco A, Costa MC. PMID: 41304974 [PubMed]
	Disease-Modifying Treatment Options in Very Early Onset Multiple Sclerosis-What Choices Are There for Onset Under 5 Years of Age? A Systematic Review. J Clin Med Craiu D, Dica AD, Pomeran C, Pescaru G, Menascu S, Simu M. PMID: 41303170 [PubMed]
	Evolving the Diagnosis of Multiple Sclerosis: A New Landscape in Light of the 2024 McDonald Criteria. Biomedicines Samara A, Ontaneda D. PMID: 41301685 [PubMed]
	Analysis of the Structural Characteristics and Psychometric Properties of the Multiple Sclerosis Intimacy and Sexuality Questionnaire (MSISQ-15): A Systematic Review and Meta-Analysis. Diagnostics (Basel) Córdoba-Peláez MM, Molina-Torres G, Rutkowska A, Rutkowski S, Rubio-Arias JÁ. PMID: 41300861 [PubMed]
	Long Non-Coding RNAs in Multiple Sclerosis-Differential Expression and Functional Implications. Genes (Basel) Misra K, Nerkar A, Clarelli F, Sorosina M, Esposito F. PMID: 41300779 [PubMed - indexed for MEDLINE]
	The ABILHAND-23 Patient Reported Outcome Measure in Secondary Progressive Multiple Sclerosis: A Cross-Sectional Analysis With the Nine Hole Peg Test. Brain Behav Apap Mangion S, Wade C, Williams T, Bianchi A, Angelis F, Wright S, John N, Doshi A, Calvi A, Oraluzume O, Leibowitz M, Vecchio G, Blackstone J, Braisher M, Favarato G, Nicholas J, Farrell R, Chataway J, UCL MS. PMID: 41299878 [PubMed - indexed for MEDLINE]
	Cost-effectiveness analysis of the MYO Armband(Â®) device in combination with specifically designed video games for upper limb rehabilitation in people with multiple sclerosis. J Neuroeng Rehabil Marcos-Antón S, Cano-de-la-Cuerda R, Aranda-Reneo I, Jardón-Huete A, Oña-Simbaña ED, Oliva-Moreno J. PMID: 41299524 [PubMed - as supplied by publisher]
	A Retrospective Study of 116 Multiple Sclerosis Patients with Dimethyl Fumarate Treatment in a Single Institution in Japan. Intern Med Sato S, Uwatoko H, Yaguchi H, Yamada M, Sato K, Kawashima A, Fukazawa T, Yabe I. PMID: 41297949 [PubMed - as supplied by publisher]
	Purinergic Signaling in Stroke and Multiple Sclerosis: Prospects for Therapies. Neuropharmacology Cisneros-Mejorado A, Colom-Casasnovas A, Pérez-Samartín A, Matute C. PMID: 41297583 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 42805

Seite 1 von 2141

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung